ArticleBMC medicine2022

Improving on-treatment risk stratification of cancer patients with refined response classification and integration of circulating tumor DNA kinetics.

Jiawei Lv et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.